Navigation Links
NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
Date:2/15/2011

RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today that NASDAQ has removed TLCR from the NASDAQ Biotechnology Index(R) (Nasdaq: NBI) in anticipation of the company's pending acquisition by Grifols S.A. The change takes effect Feb. 15 prior to the market's opening.

This customary NASDAQ policy is intended to provide stockholders with advance notice of a company's anticipated merger or acquisition in order to allow them time to sell their position. If the acquisition is not completed, NASDAQ plans to reinstate Talecris in the Biotechnology Index during the following semi-annual re-ranking of securities. Talecris was initially added to the NASDAQ Biotechnology Index on May 24, 2010.  

The Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is re-ranked semi-annually in May and November.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com


'/>"/>
SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
3. Mylan Announces Voluntary De-listing of 1.25% Senior Convertible Notes Due 2012 from Nasdaq
4. Accuray Elevated to NASDAQ Global Select Market
5. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
6. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
7. Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
8. NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
9. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
10. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
11. Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):